Treatment News

Aradigm to Present at the Biotechnology Industry Organization (BIO) CEO & Investor Conference 2014 on February 11

2.3 from 3 votes
Wednesday, February 05, 2014

HAYWARD, Calif. - Aradigm Corporation (OTCBB:ARDM) (the "Company")  announced that President and Chief Executive Officer, Igor Gonda, Ph.D., will present at the 16th Annual BIO CEO & Investor Conference 2014 on Tuesday, February 11, 2014, at 10:30 a.m. ET. The event will be held at the Waldorf-Astoria Hotel in New York, New York.

Interested parties can access a live audio webcast and slide presentation at An archived presentation will be available on the Company's Web site for 14 days.

About Aradigm

Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases. The Company has product candidates addressing the treatment of bronchiectasis, non-TB mycobacteria, cystic fibrosis, inhalation tularemia and anthrax infections, and prevention of respiratory and other diseases in tobacco smokers through smoking cessation.

More information about Aradigm can be found at

Aradigm and the Aradigm Logo are registered trademarks of Aradigm Corporation.



Aradigm Corporation

Nancy Pecota, 510-265-8800

Chief Financial Officer

Source: Aradigm Corporation
2.3 from 3 votes
Free Newsletter
Related Videos